128 related articles for article (PubMed ID: 3598620)
21. Procarbazine, carmustine, and vincristine (PBV) for chemotherapy pre-treated patients with recurrent glioblastoma: a single-institution analysis.
Kuhnhenn J; Kowalski T; Steenken S; Ostermann K; Schlegel U
J Neurooncol; 2012 Sep; 109(2):433-8. PubMed ID: 22744756
[TBL] [Abstract][Full Text] [Related]
22. Treatment of esthesioneuroblastoma with chemotherapy: a report of two cases.
Heros DO; Hochberg FH
J Neurooncol; 1988 Sep; 6(2):141-5. PubMed ID: 3225636
[TBL] [Abstract][Full Text] [Related]
23. [Survival of children with primitive neuroectodermal tumors and malignant ependymomas of the central nervous system after treatment with 8 cytostatic agents in one day. A report of the Children's Cancer Group].
Röttinger EM
Strahlenther Onkol; 1995 May; 171(5):303-4. PubMed ID: 7770788
[No Abstract] [Full Text] [Related]
24. Treatment of advanced esthesioneuroblastoma with high-dose chemotherapy and autologous bone marrow transplantation. A case report.
O'Conor GT; Drake CR; Johns ME; Cail WS; Winn HR; Niskanen E
Cancer; 1985 Jan; 55(2):347-9. PubMed ID: 3880658
[TBL] [Abstract][Full Text] [Related]
25. [Assessment of procarbazine, vincristine and lomustine association (PCV protocol) in oligodendroglioma and mixed glioma].
Bouffet E; Mornex F; Jouvet A; Thiesse P; Mertens P; Helfre S; Sindou M; Bret P
Bull Cancer; 1997 Oct; 84(10):951-6. PubMed ID: 9435796
[TBL] [Abstract][Full Text] [Related]
26. Efficacy of adjuvant therapy with procarbazine, MCNU, and vincristine for oligodendroglial tumors.
Wakabayashi T; Kajita Y; Mizuno M; Nagasaka T; Yoshida J
Neurol Med Chir (Tokyo); 2001 Mar; 41(3):115-9; discussion 119-20. PubMed ID: 11372553
[TBL] [Abstract][Full Text] [Related]
27. Aggressive oligodendroglioma: a chemosensitive tumor.
Cairncross JG; Macdonald DR; Ramsay DA
Neurosurgery; 1992 Jul; 31(1):78-82. PubMed ID: 1641113
[TBL] [Abstract][Full Text] [Related]
28. Phase II trial of nitrogen mustard, vincristine, and procarbazine in patients with recurrent glioma: North Central Cancer Treatment Group results.
Galanis E; Buckner JC; Burch PA; Schaefer PL; Dinapoli RP; Novotny PJ; Scheithauer BW; Rowland KM; Vukov AM; Mailliard JA; Morton RF
J Clin Oncol; 1998 Sep; 16(9):2953-8. PubMed ID: 9738563
[TBL] [Abstract][Full Text] [Related]
29. [Acute signs and symptoms of toxicity due to the BOPP regimen (BCNU, vincristine, procarbazine, cisplatin) during treatment of high-grade astrocytoma].
Jeremić B; Grujicić D; Jevremović S; Mijatović Lj
Srp Arh Celok Lek; 1991; 119(9-10):256-8. PubMed ID: 1806994
[TBL] [Abstract][Full Text] [Related]
30. Chemotherapy of recurrent esthesioneuroblastoma. Case report and review of the literature.
Goldsweig HG; Sundaresan N
Am J Clin Oncol; 1990 Apr; 13(2):139-43. PubMed ID: 2180272
[TBL] [Abstract][Full Text] [Related]
31. Radiation and chemotherapy improve outcome in oligodendroglioma.
Allison RR; Schulsinger A; Vongtama V; Barry T; Shin KH
Int J Radiat Oncol Biol Phys; 1997 Jan; 37(2):399-403. PubMed ID: 9069313
[TBL] [Abstract][Full Text] [Related]
32. [Role of chemotherapy in the treatment of esthesioneuroblastoma in children. Apropos of 3 case reports].
Harousseau JL; Mechinaud F; Rialland X; Milpied N; Nomballais F; Cohen JY; Cuillière JC; Legent F
Ann Pediatr (Paris); 1988 Jun; 35(6):383-6. PubMed ID: 3046463
[No Abstract] [Full Text] [Related]
33. Procarbazine, lomustine, and vincristine (PCV) chemotherapy for anaplastic astrocytoma: A retrospective review of radiation therapy oncology group protocols comparing survival with carmustine or PCV adjuvant chemotherapy.
Prados MD; Scott C; Curran WJ; Nelson DF; Leibel S; Kramer S
J Clin Oncol; 1999 Nov; 17(11):3389-95. PubMed ID: 10550132
[TBL] [Abstract][Full Text] [Related]
34. Successful combination chemotherapy (vincristine, procarbazine, etoposide, and prednisolone) in the treatment of inoperable, radioresistant low grade astrocytoma: a case report.
Maipang MVasiknanonte P; Janjindamai SHirunpat S
J Med Assoc Thai; 2000 Dec; 83(12):1525-9. PubMed ID: 11253894
[TBL] [Abstract][Full Text] [Related]
35. Superiority of post-radiotherapy adjuvant chemotherapy with CCNU, procarbazine, and vincristine (PCV) over BCNU for anaplastic gliomas: NCOG 6G61 final report.
Levin VA; Silver P; Hannigan J; Wara WM; Gutin PH; Davis RL; Wilson CB
Int J Radiat Oncol Biol Phys; 1990 Feb; 18(2):321-4. PubMed ID: 2154418
[TBL] [Abstract][Full Text] [Related]
36. Phase II trial with BCNU plus alpha-interferon in patients with recurrent high-grade gliomas.
Brandes AA; Scelzi E; Zampieri P; Rigon A; Rotilio A; Amista P; Berti F; Fiorentino MV
Am J Clin Oncol; 1997 Aug; 20(4):364-7. PubMed ID: 9256890
[TBL] [Abstract][Full Text] [Related]
37. Combined intra-arterial chemotherapy followed by radiation in astrocytomas.
Watne K; Hannisdal E; Nome O; Hager B; Wester K; Heier M; Hirschberg H
J Neurooncol; 1992 Sep; 14(1):73-80. PubMed ID: 1469466
[TBL] [Abstract][Full Text] [Related]
38. Chemotherapy for advanced esthesioneuroblastoma: the Mayo Clinic experience.
McElroy EA; Buckner JC; Lewis JE
Neurosurgery; 1998 May; 42(5):1023-7; discussion 1027-8. PubMed ID: 9588546
[TBL] [Abstract][Full Text] [Related]
39. [Intra-arterial chemotherapy of local recurrences of gastrointestinal tumors].
Heim ME
Z Gastroenterol Verh; 1989 Jul; 24():194-5. PubMed ID: 2474950
[No Abstract] [Full Text] [Related]
40. Myeloablative chemotherapy for recurrent aggressive oligodendroglioma.
Cairncross G; Swinnen L; Bayer R; Rosenfeld S; Salzman D; Paleologos N; Kaminer L; Forsyth P; Stewart D; Peterson K; Hu W; Macdonald D; Ramsay D; Smith A;
Neuro Oncol; 2000 Apr; 2(2):114-9. PubMed ID: 11303620
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
